Reuters logo
BRIEF-Nuvo Pharma Announces Normal Course Issuer Bid
November 30, 2017 / 12:34 PM / in 13 days

BRIEF-Nuvo Pharma Announces Normal Course Issuer Bid

Nov 30 (Reuters) - Nuvo Pharmaceuticals Inc:

* NUVO PHARMACEUTICALS™ ANNOUNCES NORMAL COURSE ISSUER BID

* NUVO PHARMACEUTICALS - AUTHORIZED TO ACQUIRE UP TO MAXIMUM OF 919,819 OF ITS COMMON SHARES FOR CANCELLATION OVER NEXT 12 MONTHS​

* NUVO PHARMACEUTICALS INC - ‍PURCHASES UNDER NORMAL COURSE ISSUER BID WILL BE FUNDED THROUGH AVAILABLE CASH​

* NUVO PHARMACEUTICALS INC - ‍NUVO MAY BEGIN TO PURCHASE COMMON SHARES ON OR ABOUT DECEMBER 4, 2017 AND BID WILL TERMINATE ON DECEMBER 3, 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below